Let’s Collaborate

You are invited to participate in a research study to help test new treatments for IPF related cough.

 
 

Study Description

The purpose of this study is to evaluate the efficacy of an investigational study drug for treatment of persistent cough in patients with Idiopathic Pulmonary Fibrosis (IPF) and understand the impact on patients cough symptoms over time.

 
 
Spartenburg+Fogarty.jpg

Principal Study Investigator

Charles Fogarty, M.D.
Pulmonologist, Principal Investigator
Spartenburg Medical Research
clinicaltrials@monarcbio.com
(888) 550-3078 ext. 101

 

Do I Qualify?

  • Must live in the United States

  • Must be 40+ Years of Age

  • Have a confirmed diagnosis of IPF from a doctor

  • Be willing to participate in a clinical trial

  • Additional criteria will be assess by study staff

  • Compensation for Participation & Travel will be provided (*subject to qualifying)